Prevalence of hypothyroidism in Finland--a nationwide prescription study
- PMID: 20809083
- DOI: 10.1007/s00228-010-0884-4
Prevalence of hypothyroidism in Finland--a nationwide prescription study
Abstract
Purpose: The aim of this study was to estimate the 1-year prevalence of levothyroxine-treated hypothyroidism in Finland.
Methods: Data on all individuals who had regularly purchased levothyroxine sodium tablets during 2007 were retrieved from the nationwide Finnish Drug Prescription Database. The prevalence rates and 95% confidence intervals were calculated per 100 individuals assuming a Poisson distribution.
Results: In total, 189,027 individuals (84% female) were identified as using levothyroxine tablets, which translated into a 1-year prevalence of hypothyroidism of 3.6%. The disease was notably more common in females (5.9%) than in males (1.2%), with a gender prevalence rate ratio (PRR) of 4.5. Prevalence increased with age. A comparison of five university hospital districts revealed that the prevalence rates were fairly stable regionally, with the lowest rate being 3.1% and the highest 4.4%; the regional PRR was 1.3.
Conclusions: To the best of our knowledge, this nationwide prescription study includes the largest population of reported levothyroxine users to date. This comprehensive data justifies estimating the gender- and age-specific prevalence of hypothyroidism in Finland.
Similar articles
-
Increased risk of levothyroxine-treated hypothyroidism preceding the diagnosis of rheumatoid arthritis: a nationwide registry study.Clin Exp Rheumatol. 2014 Jul-Aug;32(4):455-9. Epub 2014 Jun 6. Clin Exp Rheumatol. 2014. PMID: 24959977
-
Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.Endocrine. 2017 Oct;58(1):143-152. doi: 10.1007/s12020-017-1242-4. Epub 2017 Feb 2. Endocrine. 2017. PMID: 28155170
-
Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study.Front Endocrinol (Lausanne). 2021 May 13;12:680647. doi: 10.3389/fendo.2021.680647. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34054737 Free PMC article.
-
Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.Drugs Aging. 2005;22(1):23-38. doi: 10.2165/00002512-200522010-00002. Drugs Aging. 2005. PMID: 15663347 Review.
-
Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine.Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):57-75. doi: 10.1016/j.beem.2014.10.004. Epub 2014 Oct 25. Best Pract Res Clin Endocrinol Metab. 2015. PMID: 25617173 Review.
Cited by
-
Prevalence and sociodemographic determinants of selected noncommunicable diseases among the general population of Cyprus: A large population-based cross-sectional study.Chronic Dis Transl Med. 2023 May 9;9(3):222-237. doi: 10.1002/cdt3.70. eCollection 2023 Sep. Chronic Dis Transl Med. 2023. PMID: 37711870 Free PMC article.
-
Prevalence and factors associated with chronic use of levothyroxine: A cohort study.PLoS One. 2021 Dec 20;16(12):e0261160. doi: 10.1371/journal.pone.0261160. eCollection 2021. PLoS One. 2021. PMID: 34928965 Free PMC article.
-
Prevalence of Hypothyroidism in Children and Adolescents of Fars Province (Southern Iran): A Nationwide Prescription Study, 2018-2019.Arch Iran Med. 2022 Jul 1;25(7):417-421. doi: 10.34172/aim.2022.69. Arch Iran Med. 2022. PMID: 36404507 Free PMC article.
-
Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism.Clin Drug Investig. 2019 Feb;39(2):187-195. doi: 10.1007/s40261-018-0740-3. Clin Drug Investig. 2019. PMID: 30552650 Free PMC article.
-
Comorbidities of Prurigo Nodularis in Finland Between 1996 and 2019.Acta Derm Venereol. 2021 Jul 30;101(7):adv00508. doi: 10.2340/00015555-3872. Acta Derm Venereol. 2021. PMID: 34230981 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical